Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure

Korean Journal of Internal Medicine

Volumn 22, Issue 2, 2007, Pages 93-100

  Choi, Won Choong ^a   Arnaout, Walid C ^b   Villamil, Federico G ^b   Demetriou, Achilles A ^b   Vierling, John M ^b  

^a Inje University College of Medicine   (South Korea)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Acute liver failure; Factor V; Fulminant hepatic failure; Liver transplantation

Indexed keywords

PARACETAMOL;

ACCURACY; ADULT; AGED; ARTICLE; CLICHY PROGNOSTIC CRITERIA; CLINICAL ARTICLE; FEMALE; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; LIVER FAILURE; LONDON PROGNOSTIC CRITERIA; MALE; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL; ADOLESCENT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; HOSPITALIZATION; LIVER TRANSPLANTATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 34748909507     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2007.22.2.93     Document Type: Article

References (33)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseases. p. 282-292, New York, Grune & Stratton, 1970
2. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6:97-106, 1986
3. Gimson AE, O'Grady J, Ede RJ, Portmann B, Williams R. Late onset hepatic failure: clinical, serological and histological features. Hepatology 6:288-294, 1986
4. Williams R. Classification, etiology, and considerations of outcome in acute liver failure. Semin Liver Dis 16:343-348, 1996
5. Tandon BN, Bernauau J, O'Grady J, Gupta SD, Krisch RE, Liaw YF, Okuda K, Acharya SK. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol 14:403-404, 1999
6. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 342:273-275, 1993
7. Lee WM. Acute liver failure. N Engl J Med 329:1862-1872, 1993
8. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 16:415-425, 1996
9. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E. Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7:143-150, 1988
10. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-445, 1989
11. Riordan SM, Williams R. Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 6:170-173, 2000
12. Bernuau J, Samuel D, Durand F, Saliba F, Bourliere Meal. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V below 50% of normal. Hepatology 14:49A, 1991
13. Bernuau J. Selection for emergency liver transplantation. J Hepatol 19:486-487, 1993
14. Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, Degott C, Bezeaud A, Rueff B, Benhamou JP. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6:648-651, 1986
15. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. Ann Surg 222:109-119, 1995
16. Shakil AO, Kramer D, Mazariegos GV, Fung JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 6:163-169, 2000
17. Denninger J, Durand F, Benhamou JP. Underestimation of coagulation factor V level in frozen-thawed plasma samples from patients with acute and chronic liver disease: a prospective study. Hepatology 16:277A, 1992
18. Watanabe FD, Shackleton CR, Cohen SM, Goldman DE, Arnaout WS, Hewitt W, Colquhoun SD, Fong TL, Vierling JM, Busuttil RW, Demetriou AA. Treatment of acetaminophen-induced fulminant hepatic failure with a bioartificial liver. Transplant Proc 29:487-488, 1997
19. Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozqa J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure: a phase I clinical trial. Ann Surg 225:484-491, 1997
20. Bland M. An introduction to medical statistics. 2nd ed. Oxford, Oxford University Press, 1995
21. O'Grady J. Acute liver failure. J R Coll Physicians Lond 31:603-607, 1997
22. Riordan SM, Williams R. Cause and prognosis in acute liver failure. Liver Transpl Surg 5:86-89, 1999
23. Riordan SM, Williams R. Fulminant hepatic failure. Clin Liver Dis 4:25-45, 2000
24. Pauwels A, Mostefa-Kara N, Florent C, Levy VG. Emergency liver transplantation for acute liver failure: evaluation of London and Clichy criteria. J Hepatol 17:124-127, 1993
25. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, Stribling R, Crippin JS, Flamm S, Somberg KA, Rosen H, McCashland TM, Hay JE, Lee WM. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 5:29-34, 1999
26. Campbell DA Jr, Ham JM, McCurry KR, Lucey MR, Turcotte JG, Merion RM. Liver transplant for fulminant hepatic failure. Am Surg 57:546-549, 1991
27. Devictor D, Desplanques L, Debray D, Ozier Y, Dubousset AM, Valayer J, Houssin D, Bernard O, Huault G. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16:1156-1162, 1992
28. Emond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 96:1583-1588, 1989
29. Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria. J Hepatol 26:62-68, 1997
30. Izumi S, Langley PG, Wendon J, Ellis AJ, Pernambuco RB, Hughes RD, Williams R. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23:1507-1511, 1996
31. Dhiman RK, Seth AK, Jain S, Chawla YK, Dilawari JB. Prognostic evaluation of early indicators in fulminant hepatic failure by multivaliative analysis. Dig Dis Sci 43:1311-1316, 1998
32. Stevens AC, Busuttil R, Han S, Baquerizo A, Fair J, Shrestha R. An interim analysis of a phase II/III prospective randomized, multicenter, controlled trial of the Hepatassist bioartificial liver support system for the treatment of fulminant hepatic failure. Hepatology 34:299A, 2001
33. Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS 2nd, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Am Surg 239:660-667, 2004